葛兰素史克起诉 莫德纳 侵犯 COVID 疫苗在美国的专利权

Reuters
Oct 15, 2024

((自动化翻译由路透提供,请见免责声明 ))

路透10月15日 - 葛兰素史克公司 周二在特拉华州联邦法院起诉莫德纳公司 ,称其大片COVID-19疫苗Spikevax侵犯了葛兰素史克公司在信使核糖核酸(mRNA) 技术方面的专利权。

诉讼称,莫德纳 公司用于将 mRNA 运送到人体内的脂质纳米粒子侵犯了葛兰素史克公司的多项类似创新专利。葛兰素史克公司今年 4 月在同一法院对辉瑞公司和 BioNTech 公司的 COVID-19 疫苗提起了相关诉讼 (link)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10